ADARx Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ADRX | GPCR | ARWR | ALEC | PRTA | MBX | |
|---|---|---|---|---|---|---|
| Market cap | 1.92B | 1.71B | 8.58B | 232.25M | 432.77M | 2.51B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -11.3 | -12.3 | -2.8 | -5.5 | -13.1 |
| Price/book | -0.8 | 1.3 | 18.4 | -23.4 | 1.5 | 6.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −7.13% | −15.40% | +68.88% | −30.43% | −14.59% | +267.17% |
| Today | +1.07% | −6.38% | −3.22% | 0.00% | −4.64% | −2.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ADRX news ›Retension Pharmaceuticals IPO priced at $12, raising $45 million
As seen on the 24/7 Wall St. homepage on October 9, 2026. Priced at $12, raising roughly $45 million Retension Pharmaceuticals priced at $12 a share, locking in about $45 million from 3.75 million shares with Leerink Partners and…
U.S. IPO Weekly Recap: Biotech IPOs Keep Flowing As Data Center Developer DayOne Joins The Pipeline
Seeking Alpha - Two biotechs priced IPOs this past week and more joined the pipeline, along with a billion dollar data center developer, an emerging markets fintech, and a dental treatment company. - While market jitters have kept some IPO…
XORTX Moves to File Health Canada Trial Application for XRx-026 Gout Program
The latest update is out from XORTX Therapeutics Inc ( (XRTX) ). More about XORTX Therapeutics Inc Average Trading Volume: 201,993 Current Market Cap: $3.14M For detailed information about XRTX stock, go to TipRanks’ Stock Analysis page.
Eli Lilly-backed TRex Bio closes day flat after IPO
TRex Bio closes at $14 IPO price despite volatility in its trading debut. Read more here. - TRexBio(TRXB), which is backed by Eli Lilly (LLY), closed Friday, its first day of trading, at its IPO price, $14. - Shares opened at $13.50. They…
Aspen Neuroscience files for Nasdaq IPO with patient-derived Parkinson's cell therapy
As seen on the 24/7 Wall St. homepage on October 9, 2026. Aspen Neuroscience files for Nasdaq IPO as ASPE Aspen Neuroscience filed its S-1 to list on Nasdaq, giving public investors a rare direct shot at patient-derived cell therapy for…
Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share
(LLY:NYSE) Seeking Alpha - TRex Bio (TRXB) prices IPO at $14 per share, offering 8.33 million shares to the public, as the clinical-stage biotech company focuses on developing immunoregulatory medicines targeting tissue regulatory T-cell…
Atrium Therapeutics Raises $50 Million Private Placement To Advance Precision Cardiology Pipeline
Atrium Therapeutics entered into a securities purchase agreement with institutional investors for a $50 million private placement to support development of its precision cardiology pipeline. Atrium agreed to sell approximately 5.17 million…
Vinci Pharmaceuticals Raises More Than $8 Million Series A To Advance EPIPLANT Platform
Vinci Pharmaceuticals closed a Series A financing of more than $8 million to advance development of its EPIPLANT sustained-release drug delivery platform for retinal diseases. The financing was led by Dynagrow Capital, with additional…
Bambusa Therapeutics pursues IPO to push eczema and inflammation drugs toward trials
Bambusa is going after unmet needs across skin, respiratory, gastroenterology and autoimmune conditions with long-acting bispecific antibodies. It assembled its lead programs by acquiring assets from a BioNTech SE unit. One candidate is…
TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M
Law360 TRex Bio Leads 2 Drugmakers Pricing IPOs Totaling $162M By Jade Martinez-Pogue · October 9, 2026, 8:53 PM EDT Get instant access to the one-stop news source for business lawyers Email (NOTE: Free email domains not supported)…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com32
-
stocktitan.net20
-
tradingview.com15
-
seekingalpha.com9
-
pulse2.com8
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.